Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Welltower Inc. (NYSE:WELL - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 5,213 shares of the real estate investment trust's stock, valued at approximately $1,182,000.
Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC lifted its position in shares of Welltower by 7.1% during the 4th quarter. Brighton Jones LLC now owns 4,185 shares of the real estate investment trust's stock valued at $527,000 after acquiring an additional 279 shares during the period. Empowered Funds LLC increased its position in shares of Welltower by 31.7% in the first quarter. Empowered Funds LLC now owns 14,790 shares of the real estate investment trust's stock worth $2,266,000 after purchasing an additional 3,564 shares during the period. Sivia Capital Partners LLC increased its position in shares of Welltower by 7.1% in the second quarter. Sivia Capital Partners LLC now owns 1,910 shares of the real estate investment trust's stock worth $294,000 after purchasing an additional 127 shares during the period. Baird Financial Group Inc. raised its stake in Welltower by 7.3% in the second quarter. Baird Financial Group Inc. now owns 10,871 shares of the real estate investment trust's stock valued at $1,671,000 after purchasing an additional 735 shares in the last quarter. Finally, NewEdge Advisors LLC raised its stake in Welltower by 27.0% in the second quarter. NewEdge Advisors LLC now owns 12,435 shares of the real estate investment trust's stock valued at $1,912,000 after purchasing an additional 2,641 shares in the last quarter. 94.80% of the stock is currently owned by institutional investors.
Insider Transactions at Welltower
In other news, Director Andrew Gundlach purchased 5,000 shares of the business's stock in a transaction on Tuesday, August 25th. The shares were acquired at an average price of $239.47 per share, with a total value of $1,197,350.00. Following the completion of the transaction, the director owned 25,000 shares of the company's stock, valued at $5,986,750. The trade was a 25.00% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is currently owned by insiders.
Welltower Price Performance
Welltower stock opened at $237.51 on Friday. The stock's 50 day moving average is $235.54 and its 200 day moving average is $217.59. Welltower Inc. has a one year low of $163.75 and a one year high of $255.20. The firm has a market cap of $171.18 billion, a P/E ratio of 108.95, a P/E/G ratio of 1.14 and a beta of 0.76. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.16 and a quick ratio of 3.16.
Welltower (NYSE:WELL - Get Free Report) last released its quarterly earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.66 by ($0.05). The firm had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.40 billion. Welltower had a return on equity of 3.56% and a net margin of 12.15%.The firm's revenue for the quarter was up 39.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.28 EPS. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. As a group, research analysts expect that Welltower Inc. will post 6.43 EPS for the current year.
Welltower Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, August 20th. Investors of record on Wednesday, August 12th were issued a $0.85 dividend. The ex-dividend date was Wednesday, August 12th. This is a positive change from Welltower's previous quarterly dividend of $0.74. This represents a $3.40 annualized dividend and a yield of 1.4%. Welltower's dividend payout ratio (DPR) is presently 155.96%.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. Mizuho increased their price objective on shares of Welltower from $239.00 to $260.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. Royal Bank Of Canada upped their price target on shares of Welltower from $238.00 to $260.00 and gave the stock an "outperform" rating in a report on Monday, August 3rd. Cantor Fitzgerald increased their price target on shares of Welltower from $235.00 to $260.00 and gave the stock an "overweight" rating in a research report on Friday, July 31st. Evercore reissued an "outperform" rating and issued a $260.00 price objective on shares of Welltower in a research note on Thursday, July 30th. Finally, Barclays started coverage on shares of Welltower in a research report on Tuesday, July 7th. They set an "equal weight" rating and a $254.00 price objective for the company. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $246.11.
Check Out Our Latest Research Report on WELL
Welltower Profile
(
Free Report)
Welltower Inc NYSE: WELL is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower's assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.
The company's property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.
Featured Articles
Want to see what other hedge funds are holding WELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Welltower Inc. (NYSE:WELL - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
